Article
ALG6-CDG: a recognizable phenotype with epilepsy, proximal muscle weakness, ataxia and behavioral and limb anomalies.
Journal of inherited metabolic disease - 1 Sept 2016
Morava Eva, Tiemes Vera, Thiel Christian, Seta Nathalie, de Lonlay Pascale, de Klerk Hans, Mulder Margot, Rubio-Gozalbo Estela, Visser Gepke, van Hasselt Peter, Horovitz Dafne D G, de Souza Carolina Fischinger Moura, Schwartz Ida V D, Green Andrew, Al-Owain Mohammed, Uziel Graciella, Sigaudy Sabine, Chabrol Brigitte, van Spronsen Franc-Jan, Steinert Martin, Komini Eleni, Wurm Donald, Bevot Andrea, Ayadi Addelkarim, Huijben Karin, Dercksen Marli, Witters Peter, Jaeken Jaak, Matthijs Gert, Lefeber Dirk J, Wevers Ron A
Abstract excerpt
INTRODUCTION: Alpha-1,3-glucosyltransferase congenital disorder of glycosylation (ALG6-CDG) is a congenital disorder of glycosylation. The original patients were described with hypotonia, developmental disability, epilepsy, and increased bleeding tendency. METHODS: Based on Euroglycan database registration, we approached referring clinicians and collected comprehensive data on 41 patients. RESULTS: We found...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
